Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• Record-high drug shortages threaten patient health and safety
• 600-mg loading dose of clopidogrel reduced infarct size in STEMI patients
• Angiotensin receptor blockers may decrease mortality risk in calcific aortic stenosis
• CHD remains leading cause of death in Americans, despite recent decline
• COSS: Ipsilateral ischemic stroke not reduced through extracranial-intracranial bypass surgery
• CVD risk increased in women with human papillomavirus
• Echocardiographic variables after LVAD surgery associated with adverse outcomes
• Ex-DHF: Exercise training improves exercise capacity, diastolic function in HF patients
• FDA advisory committee recommends synergy ablation system
• HF hospitalizations among Medicare patients have declined substantially
• Laser lead removal safe for older patients
• Low vitamin C intake associated with worse outcomes for HF patients
• Metal detector use safe for patients with implanted cardiac rhythm devices
• Stroke risk increased in poorer countries
• US sodium intake higher than dietary guidelines recommend
• Women experience more comorbidities after PCI
• The pace of medical innovation
• SATURN and AIM-HIGH: ‘Back down to planet Earth’ Roger S. Blumenthal, MD; Seth S. Martin, MD, MHS, FACC, FAHA, FASPC
• FDA approves new balloon-expandable stent to treat narrowed iliac arteries
• FDA committee recommends new drug applications for ezetimibe, simvastatin
• Fenofibric acid may not lower risk for MI, stroke
• Non-surgical aortic valve repair device approved
• Cardiac stress imaging more likely among patients treated by physicians who bill for these tests
• ADAPT-DES: Platelet responsiveness predicted stent thrombosis
• Aerobic exercise safe for patients with implantable defibrillators
• ALPHEE: Celivarone no better than placebo for preventing sudden cardiac death, ICD triggering
• ATLAS ACS: Adding rivaroxaban to antiplatelet therapy reduced death rates in ACS
• Beta-blockers may prevent complications from breast cancer therapy
• Cangrelor maintained platelet inhibition without major bleeding for patients who require CABG
• Cardioprotective effects of diabetes drugs examined
• CPORT-E: Elective angioplasty patients fare well in hospitals without on-site cardiac surgery
• Dronedarone doubled mortality risk in halted PALLAS study
• ELEVATE-TIMI 56: High-dose clopidogrel reduced platelet reactivity in CYP2C19*2 carriers
• Evacetrapib boosts HDL, lowers LDL levels
• Full coverage of post-MI drugs reduced vascular event rates, out-of-pocket costs
• ISAR-REACT 4: Abciximab-heparin combo, bivalirudin similarly reduced risk for death
• MUSTELA: Coronary thrombectomy reduced ST-segment elevation but not infarct size in certain STEMI patients
• PARIS: Nonadherence to DAPT associated with ischemic, bleeding events
• POWER: Telephone coaching as effective for weight loss as in-person counseling
• Resolute stent showed positive 1-year results in patients with diabetes
• RIFLE STEACS: Radial approach may be preferable to femoral approach in STEMI patients
• Role of HDL in predicting, preventing CVD questionable
• SWEETHEART: Number of new diabetes cases higher in women